Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards

Life Health > Health Insurance > Life Insurance Strategies

Company Sets Up Hemophilia Product Access Program

Your article was successfully shared with the contacts you provided.

Grifols Inc. is setting up a support system for individuals with a serious hereditary disease who lose access to health coverage.

Grifols, Los Angeles, a unit of Grifols S.A., Barcelona, says its new PatientCare program will provide one kind of support for patients with hemophilia who lose insurance coverage, and another type of assistance for individuals who believe their need for assistance will be temporary.

To qualify for the program, patients must meet financial eligibility requirements and document difficulty getting health coverage, Grifols says.

The program will provide access both to therapies used to treat Hemophilia A, or Factor VIII deficiency, and Hemophilia B, which is also known as Factor IX deficiency.

More information about the program is on the Web at Document Link


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.